Understanding the Role of Cytokines and Neuroinflammation in COVID-19 Patients with Neurological Manifestations: Interview with Shelli Farhadian

Shelli Farhadian, MD, PhD of Yale Discusses Applying Core Learnings from Other Areas of Infectious Disease to Inform Research into COVID-19

IsoPlexis recently interviewed Shelli Farhadian, MD, PhD, Assistant Professor at Yale School of Medicine. In the interview, Dr. Farhadian discusses:

  • Discover how neurological complications differ from traditional symptoms of COVID-19
  • See how understanding the pathophysiology of COVID-19 can offer more targeted treatments for neurological issues
  • Learn how translating this knowledge reveals sources of damage from the virus, and can help explain the immune system

Watch the full interview to learn more.

Shelli Farhadian

Share This Article
Be in the Know.
Unlock Resources

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.